🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Olaparib may stop the growth of tumor cells by blocking some of ...
Status
Completed
Location
Bristol Haematology and Oncology Centre
Start Date
2011-07
Trial ID
NCT01390571
Main objective: To constitute a prospective multicentre French cohort of ki...
Status
Completed
Location
Hopital Saint-Louis
Start Date
2018-06-25
Trial ID
NCT03582436
Treatments Being Tested
RATIONALE: Studying samples of blood and tissue from smokers (closed to ent...
Status
Completed
Location
Providence Cancer Center
Start Date
2005-10
Trial ID
NCT00450281
Treatments Being Tested
RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01553175
RATIONALE: A stop-smoking plan that includes health education counseling an...
Status
Completed
Location
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Start Date
2007-12
Trial ID
NCT00666978
The overall objective is to propose a comprehensive analysis of the biologi...
Status
Unknown
Location
Direction de la Recherche Clinique et Innovation
Start Date
2018-09
Trial ID
NCT03629002
Treatments Being Tested
This research trial studies biomarkers in samples from patients with rhabdo...
Status
Withdrawn
Location
Childrens Oncology Group
Start Date
2011-11-01
Trial ID
NCT01453465
Treatments Being Tested
RATIONALE: DNA analysis of tumor tissue may help doctors predict how well p...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-21
Trial ID
NCT01466257
RATIONALE: Studying samples of tissue, blood, sputum, and urine from patien...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center - Cool Springs
Start Date
2001-05
Trial ID
NCT00899028
Treatments Being Tested
Monoclonal antibodies, such as pertuzumab and cetuximab, can block tumor gr...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-10
Trial ID
NCT00551421